Sign In
Buy ADC
$72.03
-0.650 (-0.89%)
At Close: Jun 03, 2026
5 Very Safe Dividend Stocks Can Provide a Lifetime of Monthly Passive Income
07:10am, Thursday, 19'th Jun 2025
According to the Internal Revenue Service (IRS), passive income generally includes earnings from rental activity or any trade, business, or investment in which the individual does not materially parti
If You Want $8,030 in Annual Income, Invest $25,000 in Each of these Stocks Today
03:00pm, Wednesday, 18'th Jun 2025
Using Realty Income's annualized dividend of $3.228, you could collect an easy $1,400 a year.
Differentiated PH1 payload is a spliceosome inhibitor designed to inhibit RNA splicing, leading to cancer cell death and activation of immune system through multiple mechanisms
3 Stocks That Cut You a Check Each Month
04:25am, Wednesday, 18'th Jun 2025
Retired investors who have shifted from building a nest egg to living off their accumulated savings often start to focus on dividend stocks. Going with monthly pay dividend stocks is almost like creat
Updated Phase 2 data evaluating ZYNLONTA® as a monotherapy demonstrate overall response rate (ORR) of 85% and complete response (CR) rate of 69% CR maintained in 17 of 18 patients who achieved CR, wi
The Inflation That Wasn't
09:00am, Sunday, 15'th Jun 2025
US equity markets retreated from the cusp of record-highs this week as encouraging inflation data showing surprisingly muted tariff-related inflation was spoiled by a sudden escalation in Middle East
Why I Will Never Retire
08:05am, Saturday, 14'th Jun 2025
Retirement is often misunderstood; rather than a cliff, it should be an off-ramp to more meaningful, flexible work and personal fulfillment. Research shows that abrupt retirement can negatively impact
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028
06:45am, Thursday, 12'th Jun 2025
LAUSANNE, Switzerland , June 12, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced th
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress
06:30am, Thursday, 12'th Jun 2025
ZYNLONTA® in combination with glofitamab (COLUMVI®) in patients with r/r DLBCL demonstrated clinically meaningful benefit with overall response rate (ORR) of 93.3% and a complete response (CR) rate
Compound Your Retirement With These 5 Monthly Dividend REITs
07:00am, Wednesday, 11'th Jun 2025
I focus on the power of compounding—both in life and investing—and recommend a slow, steady approach to building wealth. My top five monthly dividend REIT picks are Realty Income, LTC Properties,
Agree Realty: Add The King Of Retail REITs To Your Portfolio
04:33pm, Tuesday, 10'th Jun 2025
Agree Realty Corporation is a net lease real estate investment trust, with a top tier retailer tenant list. ADC consistently outperforms the real estate sector indexes, paying a consistent monthly div
Agree Realty Declares Monthly Common and Preferred Dividends
04:05pm, Tuesday, 10'th Jun 2025
ROYAL OAK, Mich. , June 10, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its Board of Directors has authorized, and the Company has declared, a monthl
Agree Realty: Crown Jewel Of My REIT Portfolio On Hold
06:17am, Tuesday, 10'th Jun 2025
Agree Realty consistently outperforms peers with strong AFFO growth, top-tier tenant quality, and a robust, defensive portfolio. The REIT boasts high investment-grade tenant exposure (68.3%), excellen
Agree Realty Is Ready For The Next Market Shift
08:55am, Monday, 09'th Jun 2025
Agree Realty is a defensive, growth-oriented REIT, thriving despite market volatility by focusing on essential, e-commerce-resistant tenants and disciplined portfolio management. ADC's record investme
Defence Therapeutics Receives USPTO Allowance for Patent Application Covering Next-Gen ADC Technology
03:15am, Monday, 09'th Jun 2025
Montreal, Quebec--(Newsfile Corp. - June 9, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug
